Infectious Complications After Cystectomy: A Prospective Observational Study

Sponsor
Ludwig-Maximilians - University of Munich
Study ID
NCT05153694
Status
Recruiting
Apply to this trial

Conditions

  • Bladder Cancer
  • Infection Wound
  • Infection, Bacterial
  • Infection, Hospital
  • Infections
  • Urinary Bladder Diseases
  • Urinary Tract Disease
  • Urinary Tract Infections

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cystectomy — PROCEDURE
    Removal of the urinary bladder

Study Details

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.

Key Dates

First listed
Dec 10, 2021
Start date
Dec 1, 2021
Status verified
Sep 2024
Primary completion
Dec 31, 2024
Completion
Dec 31, 2025

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Infectious parameters on the first postoperative day after cystectomy [ Time Frame: First postoperative day ]

Central Contacts

Find similar trials

Nationwide
Bladder cancer trialsOncology trialsUrology trials

Related Studies